Blood Sugar Swings: GLP-1 enhances insulin release to manage glucose
If concerning patterns emerge, the FDA may take actions such as requiring changes to a drugs labeling, issuing safety communications, or withdrawing approval in severe cases
At that time, you should then discuss with your doctor if remaining on a maintenance dose would be beneficial or even trying a no-drug period would be warranted
Timing adjustments may help with certain side effects
If you are considering how long to stay on semaglutide or thinking about stopping treatment , focus on those decisions independently rather than complicating them with dosing modifications at the same time
However, as our understanding of cell signaling and regulatory pathways has developed, so has the involvement of GSH homeostasis in many other key processes, including regulation of cell proliferation and apoptosis and post-transcriptional modification of proteins through S-glutathionylation